Wayra

Wayra is the venture arm of Telefonica, the global telecommunications operator, with a Brazilian presence in Sao Paulo deploying Seed and Series A checks in the $250k to $1M range. The fund’s positioning is strategic-financial: Wayra invests in digital solutions that can scale through Telefonica’s massive customer network across Brazil and the broader Latin America region. Healthcare relevance includes AI in healthcare, health IT, telemedicine, and digital health platforms that benefit from Telefonica’s distribution, IoT, connectivity, and B2B telecom relationships with corporate health buyers. Founders pursuing biotech, MedTech with multi-year clearance pathways, or care delivery brick-and-mortar should look elsewhere. The right counterparty is a Brazilian or LatAm technical or commercial operator with a credible Telefonica-relevant angle, ideally already running on or planning to integrate with Telefonica’s network or B2B services. Wayra is most useful when the strategic narrative writes itself: the technology genuinely benefits from telco distribution, IoT connectivity, or corporate workforce reach. Geographic and strategic advantage is access to Telefonica’s Brazilian Vivo customer base, broader LatAm Telefonica operations, and the global Wayra network across Spain, Germany, the UK, and beyond. The flip side is corporate venture cadence: pilots, procurement, and IT integration run on telco timelines, and strategic priorities can shift with Telefonica’s broader business priorities, including its periodic restructuring and asset sales. Best entry is via Wayra’s Sao Paulo team, the company’s open-innovation programs, or warm referrals from CEOs who have executed pilots inside Telefonica or Vivo. Cold inbound is read but conversion correlates with strategic clarity. Lead the pitch with the integration thesis, the commercial relationship you propose, and audited or strong unit economics. Be explicit about LGPD posture and how the product handles data flows across Telefonica’s infrastructure. Caveats: corporate venture from a global parent involves disclosure cycles, approvals, and strategic priorities that pure financial VCs do not impose. Negotiate exclusivity, MFN, and right-of-first-refusal language carefully. Confirm whether the check is balance-sheet or fund-structured, ask about reserves and follow-on policy, and clarify the Wayra Brazil entity’s relationship with the global Wayra network. Reference checks with current portfolio CEOs on commercial value realized inside Telefonica are essential. Used appropriately, Wayra is a credible Brazilian telco-strategic partner for healthcare AI founders with a credible distribution or connectivity angle; for sector-pure clinical or care delivery founders, it is the wrong vehicle.